Your browser doesn't support javascript.
loading
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial).
Mazer, C David; Siadati-Fini, Niloufar; Boehm, Johannes; Wirth, Felix; Myjavec, Andrej; Brown, Craig D; Koyner, Jay L; Boening, Andreas; Engelman, Daniel T; Larsson, Tobias E; Renfurm, Ronny; de Varennes, Benoit; Noiseux, Nicolas; Thielmann, Matthias; Lamy, Andre; Laflamme, Maxime; von Groote, Thilo; Ronco, Claudio; Zarbock, Alexander.
Afiliação
  • Mazer CD; Department of Anesthesia, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Siadati-Fini N; Department of Anesthesiology and Pain Medicine, Physiology and Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Boehm J; Anaesthesia Department, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Wirth F; Department of Cardiovascular Surgery, Technische Universität München, Munchen, Germany.
  • Myjavec A; Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany.
  • Brown CD; Department of Cardiovascular Surgery, Technische Universität München, Munchen, Germany.
  • Koyner JL; Insure (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre Munich, Munchen, Germany.
  • Boening A; Department of Cardiac Surgery, University of Hradec Kralove, Hradec Kralove, Czech Republic.
  • Engelman DT; Department of Cardiac Surgery, New Brunswick Heart Centre, Saint John, New Brunswick, Canada.
  • Larsson TE; Department of Medicine, Section of Nephrology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
  • Renfurm R; Department of Cardiovascular Surgery, Justus-Liebig-University, Giessen, Germany.
  • de Varennes B; Heart and Vascular Program, Baystate Medical Center, Springfield, Massachusetts, USA.
  • Noiseux N; Guard Therapeutics, Stockholm, Sweden.
  • Thielmann M; Global Drug Development Unit Cardio-Renal-Metabolism, Novartis Pharma AG, Basel, Switzerland.
  • Lamy A; Division of Cardiac Surgery, McGill University Faculty of Medicine, Montreal, Québec, Canada.
  • Laflamme M; Division of Cardiac Surgery, Universite de Montreal, Montreal, Québec, Canada.
  • von Groote T; Department for Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.
  • Ronco C; Department for Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.
  • Zarbock A; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
BMJ Open ; 13(4): e068363, 2023 04 06.
Article em En | MEDLINE | ID: mdl-37024249
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Injúria Renal Aguda / COVID-19 / Procedimentos Cirúrgicos Cardíacos Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Injúria Renal Aguda / COVID-19 / Procedimentos Cirúrgicos Cardíacos Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido